The Myotonic Dystrophy Foundation turned 5 this year! It was a notable milestone for a young patient organization, and one that saw enormous growth and advancement in a number of key areas, from community and family support programs and critical research initiatives to staffing and the offices we call home.
More importantly, 2012 was a breakthrough year for you, our community. Drug company leaders such as Biogen Idec, Isis and others have made real commitments to DM research, a development that brings with it incredible hope for future treatments.
As one DM researcher noted, “I’m not sure anyone would have predicted that we would find ourselves at this juncture ten years ago, but we are finally on the threshold of the first human trials for myotonic dystrophy treatments. It’s a really significant moment in DM research."
We will all have roles to play in the coming months to ensure that this progress continues, and MDF has laid the groundwork for much of our 2013 efforts already. Have a look below at the overview of our 2012 achievements and the preview of MDF plans for 2013, and let us know what you think.
2012 – A Year of Accomplishment
- Presented the 3rd MDF Annual Conference, held in San Francisco, CA to a sold-out crowd of over 300 community members, researchers and
medical professionals, featuring presentations on research advances, strategies for daily living, sessions on disease and symptom specifics and a resource fair with university research programs, vendors with products and services designed for people living with neuromuscular disorders and much more (click here to view conference presentations)
- Redesigned and relaunched the MDF website, to include easy-to-find resources for newly-diagnosed family members and the MDF Video Academy, a brand-new feature with over 14 hours of video designed to help make the wealth of information on DM genetics, symptoms, research advances and history more digestible while adding family interviews and stories from community members
- Rewrote, redesigned and updated the MDF Toolkit, formerly named the family empowerment pack, to include a new section written just for family members, a section for doctors and medical professionals, a resources section and more (click here to download the Toolkit)
- Launched the MDF Warmline to ensure that calls and emails from community members and medical professionals seeking support, advice and resources get prompt, helpful follow up
- Launched a monthly News and Updates email newsletter to keep community members apprised of news and information on myotonic dystrophy and MDF (click here to sign up)
- Published Financial Resources for People Lving With DM, compiled by Dr. Leslie Krongold and available at the MDF website to provide community members with resources and strategies for finding and accessing financial support – and there’s more to come; Leslie’s working on a state-by-state version as well
- Awarded 4 new Fund-A-Fellow postdoctoral fellowships of $100,000 each to bring talented new researchers into the field of myotonic dystrophy research, bringing MDF’s total investment in research grants to over $1,000,000 (click here for more information). This year’s Fellows are:
- Dr. Micah Bodner, Ph.D., University of Oregon, OR
- Dr. Zhihua (Tina) Gao, Ph.D., Baylor College of Medicine, TX
- Dr. Nicholas Johnson, M.D., University of Rochester Medical Center, NY
- Dr. Eric Wang, Ph.D., Harvard-MIT Division of Health Sciences and Technology, MA
- Invested in efforts to create a clinical research network, to create the best-in-class infrastructure needed to support upcoming clinical studies and trials
- Developed the MDF Patient Registry – launching in the first quarter of 2013. The MDF Registry will register and engage as many DM community members as possible to support outreach and advocacy efforts, and prepare for upcoming research studies and trials. The MDF Patient Registry will be patient-driven and web-based, so community members can see anonymous data on myotonic dystrophy, symptoms and community information in the same way researchers do, and will help:
- Raise awareness of and public interest in myotonic dystrophy
- Encourage and support research efforts by scientists in academia, biotech and pharma
- Enable patient recruitment for trials and studies
- Enable DM community members and their families to contribute to greater understanding of myotonic dystrophy
- Collect patient reported outcomes to help advocate on health investment and policy decisions
- Expanded the MDF Board of Directors, welcoming two new directors, both physicians with expertise in epidemiology, public health, advocacy and much more, to help guide the Foundation’s growth and strategic direction
- Launched TeamMDF, a volunteer program made up of DM community members that has been busy creating a number of terrific new resources for the community, including:
- MDF Physician Referral List – a list of doctors and medical professionals recommended by community members to other community members by practice, specialization and geographic location
- Peer to Peer Warmline – to offer one-to-one phone support from community members to newly-diagnosed individuals and others
- MDF Support Groups – around the U.S., with trained facilitators, support group guides, monthly facilitator resource calls and more to deliver more face-to-face support for people living with DM
- Created the MDF Fundraiser’s Guide to give interested community members additional tools and information to create grassroots fundraisers funding community support and research programs (click here to order a copy of the Guide)
- Reviewed advocacy opportunities to increase DM research and community support, identifying potential future projects such as understanding DM prevalence in the U.S., highlighting the burden of living with DM to key stakeholders and raising the visibility of DM nationwide
- Moved to new, permanent offices in Menlo Park, California, adjacent to the Stanford University Center of Excellence in myotonic dystrophy